WASHINGTON-In an agreement negotiated by the National Institutes of Health and the American Association of Health Plans, the association says it will encourage its members to “reimburse the routine patient-care costs associated with NIH-sponsored clinical trials, provided those costs are not substantially higher than the costs a plan would incur in the course of standard treatment.”
WASHINGTONIn an agreement negotiated by the National Institutes of Health and the American Association of Health Plans, the association says it will encourage its members to reimburse the routine patient-care costs associated with NIH-sponsored clinical trials, provided those costs are not substantially higher than the costs a plan would incur in the course of standard treatment.
The agreement has been reported in The New York Times, but has not been officially announced.
Oncology Decoded: Genitourinary Cancer Therapies – Teaser
February 7th 2025Manojkumar Bupathi, MD, MS, and Ben Garmezy, MD, discuss how to optimize treatment approaches for genitourinary cancers through evaluation of real-world data, sequencing strategies, and toxicity management while working to bridge care disparities between community and academic settings.